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Abstract
Background: The pathogenesis of  breast cancer remains unclear. 
Aims: To investigate the pathogenesis of  breast cancer through targeted metabolomics of  amino acids components in se-
rum of  patients with breast cancer.  
Methods: Patients with breast cancers were enrolled in our hospital between year January 1st, 2013 and December 31st, 2014. 
Targeted analysis of  amino acids was performed using ESI-QTOF-MS instrument. In vitro experiment was performed to 
determine the influence of  tryptophan towards interleukin-10 (IL-10) secretion by CD4+ T cell.
Results: Targeted metabolomics of  amino acids showed that the level of  tryptophan significantly (p<0.05) increased in 
patients with breast cancer. Furthermore, the biological function of  tryptophan was determined through determining the 
influence of  tryptophan towards IL-10 secretion using in vitro method. The addition of  tryptophan (100 uM) in the cell 
medium can significantly inhibited the secretion of  IL-10 by CD4+ T cells, as indicated by the mRNA level and protein 
concentration.  
Conclusion: The inhibition of  IL-10 secretion by CD4+ T cells is a potential pathogenesis of  breast cancer.
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Introduction
Breast cancer, developing from breast tissue, remains 
the top reason for death of  women. Unclear target in-
formation leads to the limited therapeutic drugs. There-
fore, more and more studies are carried out to find new 
therapeutic targets. The long noncoding RNA SPRY4-
IT1 has been demonstrated to be a novel prognostic 
biomarker and a potential therapeutic candidate for 
breast cancer1. The experiment performed by Finlay et 
al. showed that RNA-based TWIST1 inhibition can re-
duce breast cancer metastasis through dendrimer com-
plex2. However, all these reasons can not completely ex-
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plain the pathogenesis of  breast cancer. The elucidation 
of  a new mechanism for breast cancer pathogenesis is 
important and necessary.
Metabolomics analysis is an art-of-work technology for 
profiling all the small molecules in the biosamples (e.g., 
urine, serum, etc.). Metabolomics has been successful-
ly applied to explain the pathogenesis of  diseases, and 
the efficiency, pharmacokinetic behavior, and toxicity 
of  xenobiotics3. Metabolomics studies indicated the 
importance of  intestinal farnesoid X receptor signaling 
in the pathogenesis of  nonalcoholic fatty liver disease4. 
The experiment performed by Zhang et al. showed that 
persistent organic pollutants can modify gut microbi-
ota-host metabolic homeostasis in mice through aryl 
hydrocarbon receptor activation5.
The present study aims to compare the metabolomics 
profile of  serum between health volunteers and pa-
tients withbreast cancer to find the key inducing factor 
for breast cancer.
Materials and methods
Patients and biosamples preparation
Healthy volunteers (n=50, age, 18-70 years; body weight, 
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45-90kg) and patients with breast cancers (n=20, age, 
18-68 years; body weight, 40-85kg) were enrolled in our 
hospital between year January 1st, 2013 and December 
31st, 2014. The patients were confirmed using histolog-
ical and cytological examination methods. The patients 
with a second primary malignancy, distant metastasis, 
or any serious concomitant systemic disorders were ex-
cluded from this study. The blood samples were taken 3 
months from the beginning, and stored at -80oC. 
Targeted analysis of  amino acids components
10 uL of  serum was added in the 190 uL 95% acetoni-
trile to deproteinization. After 20-min centrifugation at 
14,000*g, the aliquots (10 uL) were dropped on the filter 
paper. The filter paper was put into a 96-well polypro-
pylene micro titer plates. 100 µL of  methanol solution 
containing isotope labeled amino acid and acylcarnitine 
internal standards (NSK-A, NSK-B, Cambridge Isotope 
Laboratories, Andover, USA). 30 min gentle shaking 
at room temperature was performed. 60 µL of  3n bu-
tanolic-HCL was added for derivatisation at 65°C after 
evaporation at 70°C for 50 min. After a second evap-
oration step the samples were reconstituted with 150 
µL of  the mobile phase (1/1 v/v isopropanol/water) 
and analyzed by flow injection analysis (FIA)-MS/MS 
using a API 4000 triple quadrupole mass spectrometer 
(AB SCIEX, Darmstadt, Germany). The mobile phase 
is 80/20 (v/v) acetonitrile/water, and changed flow 
rate was used as followed: 0.01-0.09 min, 0.26 mL/min; 
0.11-0.45 min, 0.03 mL/min; 1-1.13 min, 0.1-0.6 mL/
min; 1.13-1.4 min, 0.6 mL/min; 1.41-2 min, 0.26 mL/
min. The following mass conditions were used: Curtain 
gas, 20 psi; Collision gas, 8 psi; Ionspray voltage, 4500 
V; Temperature, 350oC; Ion source gas (GS) 1 and 2, 
35 psi. Neutral loss (NL) of  102.1 Da and precursor 
ion monitoring of  85.1 Da were used to monitoring the 
amino acids and their corresponding internal standard.
Determination of  tryptophan-induced IL-10 secre-
tion
CD4+CD25- T cells for cell culture were separated by 
EasySep™ Mouse CD4+CD25+ Regulatory T Cell 
Isolation Kit were from Stemcell Technologies, and 
were cultured with plated bound anti-CD3 (5 μg/ml) 
and soluble anti-CD28 (2 μg/ml) antibodies in the pres-
ence or absence of  tryptophan for 24 hours. After that, 
cells were collected for IL-10 mRNA expression. IL-10 
protein in culture supernatants was determined by ELI-
SA analysis.
 
Quantitative polymerase chain reaction (qPCR) 
analysis
A total of  liver RNA was extracted using TRIzol rea-
gent (Invitrogen, Carlsbad, CA), and cDNA was gen-
erated from 1 µg RNA with a SuperScript IITM Re-
verse Transcriptase kit and random oligonucleotides 
(Invitrogen, Grand Island, NY). The primer pairs were 
designed using qPrimerDepot, and messenger RNA 
quantitation was performed using the comparative cy-
cle threshold (CT) method. The expression of  mRNA 
was normalized to mouse 18S rRNA.
Results
Targeted metabolomics of  amino acids showed that the 
level of  tryptophan significantly (p<0.05) increased in 
patients with breast cancer (Figure 1). 
Figure 1. Comparison of  concentration of  tryptophan in patients with breast cancer. *, p<0.05. 
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The blood sample was taken 3 months since the begin-
ning of  the experiment. 
Furthermore, the biological function of  tryptophan was 
determined through determining the influence of  tryp-
tophan towards IL-10 secretion using in vitro method. 
The addition of  tryptophan (100 uM) in the cell medi-
um can significantly inhibited the secretion of  IL-10 by 
CD4+ T cells, as indicated by the mRNA level (Figure 
2A) and protein concentration (Figure 2B).  
Figure 2. The inhibition of  tryptophan towards IL-10 secretion by CD4+ T cells. 
CD4+ Naive T cells were isolated from mice spleno-
cytes and cultured with anti-CD3 plus anti-CD28 for 
48hrs. (A) Bar graph shows IL-10 mRNA expression 
in T cells cultured with or without tryptophan. (B) Bar 
graph shows IL-10 production in the culture media. **, 
p<0.01.
Discussion
Interleukin-10 (IL-10) is a multifunctional cytokine 
which exerts the ability to inhibit the activation and ef-
fector function of  T cells. Generally speaking, the func-
tion of  IL-10 is to limit and even terminate the immune 
reaction6. The relationship between IL-10 and patho-
genesis of  cancers has been reported in previous litera-
ture. For example, the experiment performed by Chard 
et al. has shown that a vaccinia virus armed with IL-10 
is a promising therapeutic agent for pancreatic cancer7. 
IL-10 promoter genotypes are reported to be associated 
with lung cancer8.
The present study used metabolomics method to find 
the significant elevation of  tryptophan in serum, and 
no change for other amino acids. In vitro experiment 
showed the inhibition of  tryptophan towards the IL-10 
by T cells, indicating that inhibition of  IL-10 secretion 
by elevated tryptophan was a potential pathogenesis of  
breast cancer. This phenomenon has been previously 
reported in previous literature9. 
Conclusion 
The present study gives a short communication on the 
pathogenesis of  breast cancer, which will be beneficial 
for the understanding of  mechanism of  breast cancer 
and the discovery of  new drugs for breast cancer.
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